Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben W Mol

Showing results (1-10 of 497) with videos related to

Pageof 50
Sort By:
Lancet (London, England)|January 29, 2002
Fetal heart-rate monitoringBen W Mol
Advances in Therapy|March 21, 2021
Letter to the Editor Regarding Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-analysis. Are All the Underlying Data True?Ben W Mol
JPMA. the Journal of the Pakistan Medical Association|February 26, 2023
Comment on Al-Eisa E, et al. (J Pak Med Assoc. 67: 499-507, 2017) Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndromeBen W Mol
Lancet (London, England)|March 7, 2018
Foley catheterisation versus oral misoprostol to induce labourBen W Mol
Journal of Perinatal Medicine|January 18, 2022
Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestationsBen W Mol
Journal of Pediatric and Adolescent Gynecology|March 26, 2021
Can a Three-Arm RCT With Two Active Drugs Have One Placebo?Ben W Mol
Pregnancy Hypertension|June 20, 2021
Re: Vascular endothelial growth factor C/A 2578 gene polymorphism and umbilical artery doppler in preeclamptic women. Mowad HH, Abougabal KM, Fahim AS, Shehata NAA, Ali HAA, Nasser MZ. Pregnancy Hypertens. 2019 Oct;18:173-178Ben W Mol
Evidence-Based Medicine|February 3, 2009
Active management of risk in pregnancy at term did not reduce caesarean delivery ratesBen W Mol
American Journal of Obstetrics & Gynecology MFM|February 19, 2025
Letter to the editor regarding "Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials"Ben W Mol
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 30, 2020
Valuable research starts with reliable dataBen W Mol
Pageof 50

Showing results (1-10 of 497) with videos related to

Sort By:
Pageof 50
Lancet (London, England)|January 29, 2002
Fetal heart-rate monitoringBen W Mol
Advances in Therapy|March 21, 2021
Letter to the Editor Regarding Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-analysis. Are All the Underlying Data True?Ben W Mol
JPMA. the Journal of the Pakistan Medical Association|February 26, 2023
Comment on Al-Eisa E, et al. (J Pak Med Assoc. 67: 499-507, 2017) Effects of supervised aerobic training on the levels of anti-Mullerian hormone and adiposity measures in women with normo-ovulatory and polycystic ovary syndromeBen W Mol
Lancet (London, England)|March 7, 2018
Foley catheterisation versus oral misoprostol to induce labourBen W Mol
Journal of Perinatal Medicine|January 18, 2022
Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestationsBen W Mol
Journal of Pediatric and Adolescent Gynecology|March 26, 2021
Can a Three-Arm RCT With Two Active Drugs Have One Placebo?Ben W Mol
Pregnancy Hypertension|June 20, 2021
Re: Vascular endothelial growth factor C/A 2578 gene polymorphism and umbilical artery doppler in preeclamptic women. Mowad HH, Abougabal KM, Fahim AS, Shehata NAA, Ali HAA, Nasser MZ. Pregnancy Hypertens. 2019 Oct;18:173-178Ben W Mol
Evidence-Based Medicine|February 3, 2009
Active management of risk in pregnancy at term did not reduce caesarean delivery ratesBen W Mol
American Journal of Obstetrics & Gynecology MFM|February 19, 2025
Letter to the editor regarding "Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials"Ben W Mol
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 30, 2020
Valuable research starts with reliable dataBen W Mol
Pageof 50